EA201291055A1 - Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеваний - Google Patents
Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеванийInfo
- Publication number
- EA201291055A1 EA201291055A1 EA201291055A EA201291055A EA201291055A1 EA 201291055 A1 EA201291055 A1 EA 201291055A1 EA 201291055 A EA201291055 A EA 201291055A EA 201291055 A EA201291055 A EA 201291055A EA 201291055 A1 EA201291055 A1 EA 201291055A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- eye diseases
- proteintirozinkinase
- treatment
- application
- activity inhibitors
- Prior art date
Links
- 208000030533 eye disease Diseases 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 abstract 1
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Настоящее изобретение относится к соединениям и их композициям, которые являются ингибиторами протеинтирозинкиназ. Соединения применяют для лечения глазных заболеваний, расстройств и состояний. Указанные соединения имеют формулы (I), (II) или (III), где R=(IV), (V), (VI), (VII), (VIII), (IX), (X), (XI) или (XII).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32480310P | 2010-04-16 | 2010-04-16 | |
PCT/CA2011/000390 WO2011127565A1 (en) | 2010-04-16 | 2011-04-08 | Inhibitors of protein tyrosine kinase activity and use thereof to treat ophthalmic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201291055A1 true EA201291055A1 (ru) | 2013-09-30 |
Family
ID=44788641
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201291055A EA201291055A1 (ru) | 2010-04-16 | 2011-04-08 | Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеваний |
EA201291052A EA201291052A1 (ru) | 2010-04-16 | 2011-04-08 | Ингибиторы протеинтирозинкиназной активности |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201291052A EA201291052A1 (ru) | 2010-04-16 | 2011-04-08 | Ингибиторы протеинтирозинкиназной активности |
Country Status (18)
Country | Link |
---|---|
US (3) | US8906852B2 (ru) |
EP (2) | EP2563794A4 (ru) |
JP (2) | JP2013525286A (ru) |
KR (2) | KR20130100234A (ru) |
CN (2) | CN103025740B (ru) |
AR (2) | AR080875A1 (ru) |
AU (2) | AU2011241420B2 (ru) |
CA (2) | CA2796008A1 (ru) |
CO (2) | CO6640224A2 (ru) |
EA (2) | EA201291055A1 (ru) |
MX (2) | MX2012012031A (ru) |
MY (1) | MY157319A (ru) |
NZ (2) | NZ602954A (ru) |
SG (2) | SG184883A1 (ru) |
TW (2) | TW201204734A (ru) |
UA (1) | UA108878C2 (ru) |
WO (2) | WO2011127567A1 (ru) |
ZA (2) | ZA201207482B (ru) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009026717A1 (en) * | 2007-08-29 | 2009-03-05 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
BRPI0923670A2 (pt) * | 2008-03-05 | 2013-07-30 | Methylgene Inc | inibidores da atividade de proteÍna tirosina quinase e seu uso, bem como composiÇço compreendendo os mesmos |
KR20130100234A (ko) * | 2010-04-16 | 2013-09-10 | 메틸진 인코포레이티드 | 단백질 티로신 키나아제 활성의 억제 및 안구 질환을 치료하는 이의 용도 |
US20130096135A1 (en) * | 2011-09-30 | 2013-04-18 | Methylgene Inc. | Selected Inhibitors of Protein Tyrosine Kinase Activity |
WO2013044360A1 (en) * | 2011-09-30 | 2013-04-04 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
WO2013044361A1 (en) * | 2011-09-30 | 2013-04-04 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
CA2857603C (en) | 2011-12-15 | 2016-08-02 | Pfizer Limited | Sulfonamide derivatives |
EP3200589A4 (en) | 2014-09-10 | 2018-07-25 | Temple University Of The Commonwealth System Of Higher Education | Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use |
WO2016183150A1 (en) * | 2015-05-12 | 2016-11-17 | Temple University-Of The Commonwealth System Of Higher Education | Novel sigma-2 receptor binders and their method of use |
CN108530464B (zh) * | 2017-03-02 | 2020-10-27 | 深圳海王医药科技研究院有限公司 | 一种多靶点激酶抑制剂 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050020619A1 (en) * | 2003-07-24 | 2005-01-27 | Patrick Betschmann | Thienopyridine kinase inhibitors |
KR101257343B1 (ko) * | 2004-07-30 | 2013-04-23 | 메틸진 인코포레이티드 | Vegf 수용체 및 hgf 수용체 신호전달 억제제 |
AU2006229343A1 (en) * | 2005-03-28 | 2006-10-05 | Kirin Pharma Kabushiki Kaisha | Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-Met autophosphorylation inhibiting potency |
JO2787B1 (en) * | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
ES2473341T3 (es) * | 2005-05-20 | 2014-07-04 | Methylgene Inc | Inhibidores de la se�alizaci�n del receptor del VEGF y del receptor del HGF |
BRPI0610322B8 (pt) * | 2005-05-20 | 2021-05-25 | Methylgene Inc | inibidores de sinalização de receptor de vegf e de receptor de hgf e composição farmacêutica |
ES2593279T3 (es) * | 2007-08-29 | 2016-12-07 | Methylgene Inc. | Procesos e intermedios para preparar inhibidores de cinasa heterocíclicos condensados |
WO2009026717A1 (en) * | 2007-08-29 | 2009-03-05 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
BRPI0923670A2 (pt) * | 2008-03-05 | 2013-07-30 | Methylgene Inc | inibidores da atividade de proteÍna tirosina quinase e seu uso, bem como composiÇço compreendendo os mesmos |
KR20130100234A (ko) * | 2010-04-16 | 2013-09-10 | 메틸진 인코포레이티드 | 단백질 티로신 키나아제 활성의 억제 및 안구 질환을 치료하는 이의 용도 |
WO2013044361A1 (en) * | 2011-09-30 | 2013-04-04 | Methylgene Inc. | Inhibitors of protein tyrosine kinase activity |
-
2011
- 2011-04-08 KR KR1020127029841A patent/KR20130100234A/ko not_active Application Discontinuation
- 2011-04-08 JP JP2013504076A patent/JP2013525286A/ja not_active Ceased
- 2011-04-08 AR ARP110101195A patent/AR080875A1/es unknown
- 2011-04-08 AU AU2011241420A patent/AU2011241420B2/en not_active Ceased
- 2011-04-08 MX MX2012012031A patent/MX2012012031A/es active IP Right Grant
- 2011-04-08 NZ NZ602954A patent/NZ602954A/en not_active IP Right Cessation
- 2011-04-08 KR KR1020127030161A patent/KR20130058006A/ko not_active Application Discontinuation
- 2011-04-08 TW TW100112307A patent/TW201204734A/zh unknown
- 2011-04-08 US US13/082,923 patent/US8906852B2/en not_active Expired - Fee Related
- 2011-04-08 EP EP20110768305 patent/EP2563794A4/en not_active Withdrawn
- 2011-04-08 CN CN201180029735.1A patent/CN103025740B/zh not_active Expired - Fee Related
- 2011-04-08 WO PCT/CA2011/000394 patent/WO2011127567A1/en active Application Filing
- 2011-04-08 TW TW100112308A patent/TW201204735A/zh unknown
- 2011-04-08 SG SG2012076733A patent/SG184883A1/en unknown
- 2011-04-08 CA CA2796008A patent/CA2796008A1/en not_active Abandoned
- 2011-04-08 UA UAA201211687A patent/UA108878C2/ru unknown
- 2011-04-08 SG SG2012076725A patent/SG184882A1/en unknown
- 2011-04-08 AU AU2011241422A patent/AU2011241422B2/en not_active Ceased
- 2011-04-08 JP JP2013504075A patent/JP2013523846A/ja not_active Ceased
- 2011-04-08 CN CN2011800297313A patent/CN102947315A/zh active Pending
- 2011-04-08 MX MX2012012032A patent/MX2012012032A/es not_active Application Discontinuation
- 2011-04-08 WO PCT/CA2011/000390 patent/WO2011127565A1/en active Application Filing
- 2011-04-08 EP EP11768307.8A patent/EP2563795A4/en not_active Withdrawn
- 2011-04-08 EA EA201291055A patent/EA201291055A1/ru unknown
- 2011-04-08 CA CA2796054A patent/CA2796054A1/en not_active Abandoned
- 2011-04-08 NZ NZ602948A patent/NZ602948A/en not_active IP Right Cessation
- 2011-04-08 AR ARP110101191A patent/AR080871A1/es unknown
- 2011-04-08 US US13/082,944 patent/US8455484B2/en not_active Expired - Fee Related
- 2011-04-08 MY MYPI2012004621A patent/MY157319A/en unknown
- 2011-04-08 EA EA201291052A patent/EA201291052A1/ru unknown
-
2012
- 2012-10-05 ZA ZA2012/07482A patent/ZA201207482B/en unknown
- 2012-10-09 ZA ZA2012/07557A patent/ZA201207557B/en unknown
- 2012-11-15 CO CO12207317A patent/CO6640224A2/es active IP Right Grant
- 2012-11-15 CO CO12207310A patent/CO6630193A2/es active IP Right Grant
-
2014
- 2014-06-18 US US14/308,408 patent/US20140315801A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201291055A1 (ru) | Ингибиторы протеинтирозинкиназной активности и их применение для лечения глазных заболеваний | |
EA201490042A1 (ru) | Азетидинил-фенил-, пиридил- или пиразинилкарбоксамидные производные как ингибиторы jak | |
EA201491592A1 (ru) | Соединения индолов и индазолов, активирующие ampk | |
EA201390711A1 (ru) | Гидроксиамидные соединения пиримидина в качестве ингибиторов деацетилаз белков и способы их применения | |
EA201200373A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
EA201391230A1 (ru) | Соединения и композиции в качестве ингибиторов trk | |
EA201491579A1 (ru) | Соединения оксазолидин-2-она и их применения в качестве ингибиторов pi3k | |
EA201290894A1 (ru) | Азетидиновые производные пиперидин-4-ила как ингибиторы jak1 | |
EA201490542A1 (ru) | Соединения и композиции в качестве pdgfr киназных ингибиторов | |
EA201490545A1 (ru) | СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ С-Kit | |
MA32393B1 (fr) | Composés et compositions servant d'inhibiteurs de kinases | |
EA201391682A1 (ru) | Замещенные производные индазола, активные в качестве ингибиторов киназы | |
EA201491012A1 (ru) | Гетероциклические ингибиторы глютаминазы | |
EA201691461A1 (ru) | Определенные триазолопиридины и триазолопиразины, их композиции и способы их применения | |
EA201290209A1 (ru) | Новые модуляторы бензопиран киназы | |
EA201590748A1 (ru) | Противовирусные соединения против rsv | |
EA201201665A1 (ru) | Новые соединения | |
EA201290191A1 (ru) | N1-ПИРАЗОЛОСПИРОКЕТОНОВЫЕ ИНГИБИТОРЫ АЦЕТИЛ-KoA-КАРБОКСИЛАЗЫ | |
EA201591727A1 (ru) | Соединения биариламида в качестве ингибиторов киназы | |
EA201071057A1 (ru) | Производные азетидина и циклобутана как ингибиторы jak-киназ | |
EA201490540A1 (ru) | Соединения и композиции в качестве ингибиторов с-kit киназы | |
EA201500278A1 (ru) | Пиразолилхиназолиновые ингибиторы киназы | |
EA201291099A1 (ru) | Новые иммуномодуляторные и противовоспалительные соединения | |
EA201270100A1 (ru) | Пиримидиноны в качестве ингибиторов pi3k | |
EA201391416A1 (ru) | Новые соединения в качестве модуляторов протеинкиназ |